Angiogenesis and hypoxia in the kidney (Q38086359)

28 August 2017

Angiogenesis and hypoxia in the kidney (English)

1 reference

28 August 2017

0 references

Tetsuhiro Tanaka

1

1 reference

PubMed ID

23458926

28 August 2017

Masaomi Nangaku

series ordinal

2

1 reference

PubMed ID

23458926

28 August 2017

language of work or name

English

0 references

publication date

5 March 2013

1 reference

Nature Reviews Nephrology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

211-222

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.35

28 August 2017

0 references

cites work

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoxia of the renal medulla--its implications for disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Renal preglomerular arterial-venous O2 shunting is a structural anti-oxidant defence mechanism of the renal cortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Pivotal role of pericytes in kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Molecular mechanisms and clinical applications of angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The biology of vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The role of VEGF 165b in pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Lymphatic vessels develop during tubulointerstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Biological characterization of angiopoietin-3 and angiopoietin-4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

A role for uric acid in the progression of renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Significance of postglomerular capillaries in the pathogenesis of chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Acute kidney injury and chronic kidney disease: an integrated clinical syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Methylation determines fibroblast activation and fibrogenesis in the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Microvascular endothelial injury and dysfunction during ischemic acute renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endothelial injury and dysfunction: role in the extension phase of acute renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Evidence of tubular hypoxia in the early phase in the remnant kidney model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoxia in renal disease with proteinuria and/or glomerular hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: preliminary experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular permeability factor mRNA and protein expression in human kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

A defective angiogenesis in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

VEGF(165) mediates glomerular endothelial repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Vegfa protects the glomerular microvasculature in diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Roles of angiopoietins in kidney development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endoglin in angiogenesis and vascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Circulating angiogenic factors and the risk of preeclampsia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Soluble endoglin contributes to the pathogenesis of preeclampsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endoglin upregulation during experimental renal interstitial fibrosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Thrombospondin in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Thrombospondins as anti-angiogenic therapeutic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The effect of angiostatin on vascular leakage and VEGF expression in rat retina

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Therapeutic potential of angiostatin in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

MicroRNA-mediated regulation of the angiogenic switch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Aberrant tubuloglomerular feedback and HIF-1α confer resistance to ischemia after subtotal nephrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Adaptation to hypoxia in the diabetic rat kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endothelial progenitor cells restore renal function in chronic experimental renovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

VEGF inhibition and renal thrombotic microangiopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

VEGFA and tumour angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Identification of an angiogenic mitogen selective for endocrine gland endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Proinflammatory functions of vascular endothelial growth factor in alloimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Tumors and inflammatory infiltrates: friends or foes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

The endothelial glycocalyx: composition, functions, and visualization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Protection of endothelial cells by dextran sulfate in rats with thrombotic microangiopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Endothelial progenitor cells homing and renal repair in experimental renovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Dysfunctional endothelial progenitor cells in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Mesenchymal stem cell-derived microvesicles protect against acute tubular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.35

Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells

31 March 2020

1 reference

12 December 2020

Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature

1 reference

12 December 2020

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

1 reference

12 December 2020

Altered vascular homeostasis in chronic kidney disease

1 reference

12 December 2020

Role of the microvascular endothelium in progressive renal disease.

1 reference

12 December 2020

Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.

1 reference

12 December 2020

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1

1 reference

12 December 2020

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

1 reference

12 December 2020

Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex

1 reference

12 December 2020

VEGF-A: a critical regulator of blood vessel growth

1 reference

12 December 2020

Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function

1 reference

12 December 2020

Organ protection by hypoxia and hypoxia-inducible factors

1 reference

12 December 2020

Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2013.35

1 reference

28 August 2017

1 reference

PubMed ID

23458926